Marc Feldmann Selected Research

HU 320

3/2004

A novel synthetic, nonpsychoactive cannabinoid acid (HU-320) with antiinflammatory properties in murine collagen-induced arthritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Marc Feldmann Research Topics

Disease

44	Rheumatoid Arthritis 01/2021 - 01/2002
25	Inflammation (Inflammations) 01/2022 - 03/2004
19	Necrosis 01/2020 - 01/2002
18	Arthritis (Polyarthritis) 01/2020 - 01/2003
14	Experimental Arthritis 10/2019 - 01/2003
8	Neoplasms (Cancer) 01/2021 - 01/2008
7	COVID-19 12/2022 - 01/2020
7	Atherosclerosis 11/2022 - 04/2002
7	Autoimmune Diseases (Autoimmune Disease) 03/2011 - 08/2002
6	Pain (Aches) 09/2021 - 12/2007
5	Fibrosis (Cirrhosis) 01/2022 - 12/2004
5	Infections 03/2015 - 02/2003
5	Crohn Disease (Crohn's Disease) 08/2007 - 01/2002
4	Disease Progression 01/2022 - 08/2005
4	Atherosclerotic Plaque (Atheroma) 10/2015 - 04/2004
4	Cognitive Dysfunction 03/2015 - 01/2010
4	Osteoarthritis 05/2010 - 01/2002
3	Hypoxia (Hypoxemia) 10/2020 - 08/2012
3	Wounds and Injuries (Trauma) 01/2018 - 09/2010
3	Neuroinflammatory Diseases 03/2015 - 01/2010
3	Psoriasis (Pustulosis Palmaris et Plantaris) 08/2007 - 12/2002
2	Dupuytren Contracture (Dupuytrens Contracture) 01/2022 - 07/2018
2	Arthralgia (Joint Pain) 01/2020 - 05/2010
2	Hyperalgesia 08/2011 - 12/2007
2	Postoperative Cognitive Complications 11/2010 - 09/2010
2	Chronic Disease (Chronic Diseases) 06/2008 - 01/2004
2	Ankylosing Spondylitis 08/2007 - 05/2006
2	Glomerulonephritis 04/2007 - 05/2006
2	Pathologic Processes 12/2004 - 02/2003
1	Insulin Resistance 01/2022
1	Obesity 09/2021
1	Contracture 07/2018
1	Multiple Sclerosis 01/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018

Drug/Important Bio-Agent (IBA)

42	CytokinesIBA 01/2021 - 01/2002
24	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2020 - 01/2002
11	LigandsIBA 09/2013 - 04/2002
9	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2002
9	NF-kappa B (NF-kB)IBA 12/2009 - 01/2002
8	Toll-Like Receptors (Toll-Like Receptor)IBA 11/2022 - 03/2004
8	Biological ProductsIBA 01/2015 - 01/2002
6	Interleukin-6 (Interleukin 6)IBA 10/2020 - 07/2003
6	Monoclonal AntibodiesIBA 06/2017 - 01/2002
6	Collagen Type II (Type II Collagen)IBA 09/2011 - 03/2003
5	Interleukin-10 (Interleukin 10)IBA 01/2018 - 01/2002
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2012 - 02/2003
4	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2020
4	Pharmaceutical PreparationsIBA 09/2021 - 09/2005
4	Interleukin-8 (Interleukin 8)IBA 10/2020 - 07/2003
4	ChemokinesIBA 10/2015 - 03/2004
4	Infliximab (Remicade)FDA Link 01/2015 - 01/2002
4	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 10/2014 - 05/2006
4	Etanercept (Enbrel)FDA Link 09/2013 - 05/2006
4	Matrix Metalloproteinases (MMPs)IBA 12/2009 - 07/2003
3	CollagenIBA 01/2022 - 01/2003
3	AntigensIBA 09/2015 - 02/2003
3	LipopolysaccharidesIBA 03/2015 - 03/2004
3	Transcription Factors (Transcription Factor)IBA 08/2012 - 03/2007
3	Interleukin-1 (Interleukin 1)IBA 11/2010 - 08/2005
3	AntibodiesIBA 01/2010 - 08/2005
3	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 12/2009 - 03/2004
2	InterleukinsIBA 10/2020 - 01/2010
2	Type II Tumor Necrosis Factor ReceptorsIBA 12/2019 - 10/2019
2	Adalimumab (Humira)FDA Link 07/2018 - 11/2007
2	Apolipoproteins E (ApoE)IBA 10/2015 - 02/2011
2	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 03/2015 - 12/2011
2	AngiopoietinsIBA 08/2012 - 10/2010
2	Messenger RNA (mRNA)IBA 03/2011 - 01/2008
2	ErbB Receptors (EGF Receptor)IBA 01/2011 - 10/2008
2	Interleukin-1beta (Interleukin 1 beta)IBA 09/2010 - 07/2003
2	Analgesics (Analgesic Drugs)IBA 05/2010 - 12/2007
2	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2010 - 12/2009
2	p38 Mitogen-Activated Protein KinasesIBA 04/2007 - 12/2004
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2002 - 01/2002
1	CholesterolIBA 11/2022
1	C-Type Lectins (C-Type Lectin)IBA 11/2022
1	VaccinesIBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	endotrophinIBA 01/2022
1	Calcium Gluconate (CBG)IBA 09/2021
1	AZD5153IBA 01/2021
1	InterferonsIBA 01/2020
1	Interferon Type IIBA 01/2020
1	Antirheumatic Agents (DMARD)IBA 01/2020
1	Interleukin-33IBA 12/2019
1	Tumor Necrosis Factor InhibitorsIBA 07/2018
1	Histone DemethylasesIBA 01/2018
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2018
1	Glatiramer Acetate (Copaxone)FDA Link 01/2018
1	HMGB1 Protein (HMG1)IBA 01/2018
1	GSK-J4IBA 01/2018
1	anthranilic acid (anthranilate)IBA 10/2015
1	Tryptophan (L-Tryptophan)FDA Link 10/2015
1	LipidsIBA 10/2015

Therapy/Procedure

30	Therapeutics 12/2022 - 01/2002
2	Drug Therapy (Chemotherapy) 01/2018 - 11/2010
2	Orthopedic Procedures 03/2015 - 09/2010
2	Biological Therapy 01/2008 - 11/2007
1	Immunotherapy 01/2022
1	Traction 01/2020